연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2024년 | 2023년 | 2022년 | 2021년 | 2020년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 179편 | 173편 | 163편 | 184편 | 135편 |
| 공동 | 147편 | 120편 | 115편 | 136편 | 168편 | |
| 합계 | 326편 | 293편 | 278편 | 320편 | 303편 | |
2887. Trastuzumab Emtansine Plus Pertuzumab Versus Taxane Plus Trastuzumab Plus Pertuzumab After Anthracycline for High-Risk Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: The Phase III KAITLIN Study
Ian E Krop 1, Seock-Ah Im 2, Carlos Barrios 3, Hervé Bonnefoi 4, Julie Gralow 5, Masakazu Toi 6, Paul A Ellis 7, Luca Gianni 8, Sandra M Swain 9, Young-Hyuck Im 10, Michelino De Laurentiis 11, Zbigniew Nowecki 12, Chiun-Sheng Huang 13, Louis Fehrenbacher 14, Yoshinori Ito 15, Jigna Shah 16, Thomas Boulet 17, Haiying Liu 16, Harrison Macharia 17, Peter Trask 16, Chunyan Song 16, Eric P Winer 1, Nadia Harbeck 18
Affiliations expand
J Clin Oncol. 2022 Feb 10;40(5):438-448.
Link
2886. Accuracy of preoperative clinical staging for locally advanced gastric cancer in KLASS-02 randomized clinical trial
Kim DJ, Hyung WJ, Park YK, Lee HJ, An JY, Kim HI, Kim HH, Ryu SW, Hur H, Kim MC, Kong SH, Kim JJ, Park DJ, Ryu KW, Kim YW, Kim JW, Lee JH, Yang HK, Han SU, Kim W
Front Surg. 2022 Sep 23;9:1001245.
Link
2885. Retrospective Cohort Study on the Longterm Oncologic Outcomes of Sentinel Lymph Node Mapping Methods (Dye-Only Versus Dye and Radioisotope Mapping) in Early Breast Cancer: A Propensity Score-Matched Analysis
Lim C, Kang E, Jung JG, Cheun JH, Kim HK, Lee HB, Moon HG, Han W.
Cancer Res Treat. 2022 Sep 26. doi: 10.4143/crt.2022.871. Online ahead of print.
Link
2884. Musculoskeletal Pain and the Prevalence of Rheumatoid Arthritis in Breast Cancer Patients During Cancer Treatment: A Retrospective Study
Ju Yeon Kim, Min Jung Kim, Eun Bong Lee, Tae-Yong Kim, Kyung-Hun Lee, Seock-Ah Im, Jin Kyun Park
Journal of breast cancer 2022. 25(5):404-414.
Link
2883. Response Rate and Safety of a Neoadjuvant Pertuzumab, Atezolizumab, Docetaxel, and Trastuzumab Regimen for Patients With ERBB2-Positive Stage II/III Breast Cancer: The Neo-PATH Phase 2 Nonrandomized Clinical Trial
Ahn HK, Sim SH, Suh KJ, Kim MH, Jeong JH, Kim JY, Lee DW, Ahn JH, Chae H, Lee KH, Kim JH, Lee KS, Sohn JH, Choi YL, Im SA, Jung KH, Park YH
JAMA oncology 2022. 8(9):1271-1277.
Link
2882. Do posttraumatic stress symptoms predict trajectories of sleep disturbance and fatigue in patients with breast cancer? A parallel-process latent growth model
Eun‐Jung Shim, Donghee Jeong, Dooyoung Jung, Tae‐Yong Kim, Kyung‐Hun Lee, Seock‐Ah Im, Bong‐Jin Hahm
Psychooncology 2022. 31(8):1286-1293
Link
2881. HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysis
Ryan Shea Ying Cong Tan, Whee Sze Ong, Kyung-Hun Lee , Abner Herbert Lim , Seri Park5, Yeon Hee Park , Ching-Hung Lin , Yen-Shen Lu , Makiko Ono , Takayuki Ueno, Yoichi Naito , Tatsuya Onishi, Geok-Hoon Lim , Su-Ming Tan , Han-Byoel Lee , Han Suk Ryu , Wonshik Han , Veronique Kiak Mien Tan , Fuh-Yong Wong , Seock-Ah Im, Puay Hoon Tan , Jason Yongsheng Chan, Yoon-Sim Yap
BMC medicine 2022. 20(1):105
Link
2880. The impact of race and ethnicity in breast cancer-disparities and implications for precision oncology
Kelly A Hirko, Gabrielle Rocque, Erica Reasor, Ammanuel Taye, Alex Daly, Ramsey I Cutress, Ellen R Copson, Dae-Won Lee, Kyung-Hun Lee, Seock-Ah Im, Yeon Hee Park
BMC medicine 2022. 20(1):72.
Link
2879. Determinants of Response to Talazoparib in Patients with HER2-Negative, Germline BRCA1/2-Mutated Breast Cancer
Blum JL, Laird AD, Litton JK, Rugo HS, Ettl J, Hurvitz SA, Martin M, Roché HH, Lee KH, Goodwin A, Chen Y, Lanzalone S, Chelliserry J, Czibere A, Hopkins JF, Albacker LA, Mina LA.
Clin Cancer Res. 2022 Apr 1;28(7):1383-1390.
Link
2878. Increased Apoptotic Activity in Low-Risk Myelodysplastic Syndrome
Park S, Shin DY, Park JS, Park HS, Moon SY, Yoon SS, Lee DS
J Clin Med. 2022 Aug 7;11(15):4604
Link